APA (7th ed.) Citation

LD, O., LD, S., BR, L., MM, S., SD, S., NO, W., . . . LM, P. (2024). Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer. NPJ breast cancer, 10(1), 99. https://doi.org/10.1038/s41523-024-00707-6

Chicago Style (17th ed.) Citation

LD, Otto-Dobos, et al. "Baseline Gut Microbiome Alpha Diversity Predicts Chemotherapy-induced Gastrointestinal Symptoms in Patients with Breast Cancer." NPJ Breast Cancer 10, no. 1 (2024): 99. https://doi.org/10.1038/s41523-024-00707-6.

MLA (9th ed.) Citation

LD, Otto-Dobos, et al. "Baseline Gut Microbiome Alpha Diversity Predicts Chemotherapy-induced Gastrointestinal Symptoms in Patients with Breast Cancer." NPJ Breast Cancer, vol. 10, no. 1, 2024, p. 99, https://doi.org/10.1038/s41523-024-00707-6.